Treatment of myelodysplastic syndromes with retinoic acid and 1 alpha-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a randomized study. The Scandinavian Myelodysplasia Group (SMG).

Source:http://linkedlifedata.com/resource/pubmed/id/2261951

Download in:

View as

General Info

PMID
2261951